Clinical Trial Update: Effect of NMBA on Surgical Conditions in THR [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the effect of a neuromuscular blocking agent (NMBA) on surgical conditions in total hip replacement has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain
• Surgical Recovery
• Total Hip Replacement Complications

Snippet

Sponsor: Algemeen Ziekenhuis Maria Middelares | Conditions: Surgery, Postoperative Pain | Phase 4 | Status: WITHDRAWN